3D-Printed Drugs Market: The Future of Personalized Medicine
Introduction The pharmaceutical industry is undergoing a revolutionary transformation with the advent of 3D-printed drugs. This cutting-edge technology promises to personalize medicine, enhance drug efficacy, and streamline manufacturing processes. According to FutureWise Research, the global 3D-printed drugs market in 2023 was US$ 0.33 billion, and is expected to reach US$ 0.67 billion by 2031 at a CAGR of 9.42%. To Know More - https://www.futurewiseresearch.com/healthcare-market-research/3D-Printed-Drugs/10187 What Are 3D-Printed Drugs? 3D-printed drugs are medications manufactured using additive manufacturing techniques, where drugs are built layer by layer based on digital designs. This method allows for precise control over dosage, release profiles, and even combination therapies in a single pill. The first FDA-approved 3D-printed drug, Spritam (levetiracetam), developed by Aprecia Pharmaceuticals, was introduced in 2015 for epilepsy treatment....